We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Delta Air Lines, United Airlines, American Airlines, Southwest Airlines and Ryanair Holdings
Read MoreHide Full Article
For Immediate Release
Chicago, IL – November 10, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Delta Air Lines, Inc. (DAL - Free Report) , United Airlines Holdings, Inc. (UAL - Free Report) , American Airlines Group Inc. (AAL - Free Report) , Southwest Airlines Co. (LUV - Free Report) and Ryanair Holdings plc (RYAAY - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Coronavirus Ruins Airlines' Q3 Earnings, As Well
Airline stocks have been in the pink of health over the past few years, mainly on the back of solid passenger revenues owing to robust air-travel demand. However, with the advent of coronavirus in the first quarter of 2020, things deteriorated for the entire aviation space as travel demand plummeted with people being confined to their homes in the fear of the contagion.
What is worse is that the health peril is still very much around even though more than seven months have elapsed since the disease was declared a pandemic by the World Health Organization. Consequently, airlines continue to bear the brunt of this global adversity. As an evidence, airlines fared dismally for the third successive quarter this year with losses mounting due to crippled passenger revenues.
Against this bleak backdrop, let’s recapitulate the results of a few key airline stocks for the September quarter.
Delta Air Lines kicked off the third-quarter 2020 earnings season for the aviation industry on Oct 13. This Atlanta-GA based company incurred a loss (excluding $5.17 from non-recurring items) of $3.30 per share in the September quarter, wider than the Zacks Consensus Estimate of a loss of $3.14. Also, passenger revenues plunged 83% year over year in the September quarter. In fact, due to low demand, this key metric declined 68% in the first nine months of 2020.
Akin to Delta, Chicago-based United Airlines suffered a loss in the third successive quarter of 2020. The carrier reported a loss (excluding $1.83 from non-recurring items) of $8.16 per share in the September quarter, comparing unfavorably with the Zacks Consensus Estimate of a loss of $7.63. Passenger revenues plunged 84.3% and 68.4% in the third quarter and during the first nine months of 2020, respectively.
American Airlines posted a loss (excluding 83 cents from non-recurring items) of $5.54 per share for third-quarter 2020, narrower than the Zacks Consensus Estimate of a loss of $5.62. Passenger revenues plunged 76.9% and 64.2% in the third quarter and during the first nine months of 2020, respectively.
Dallas-based low-cost carrier Southwest Airlines fared no better and announced a loss for the third consecutive quarter like its fellow airline players mentioned above. The carrier, carrying a Zacks Rank #3 (Hold) currently, incurred a loss of $1.99 per share (excluding 3 cents from non-recurring items) in the reported quarter, narrower than the Zacks Consensus Estimate of a loss of $2.44. Moreover, passenger revenues plunged 71.2% and 61.2% in the third quarter and during the first nine months of 2020, respectively.
With airlines having performed disappointingly in the third quarter, echoing the first two quarters’ trend, the million-dollar question is whether things will look up for the stocks from hereon. Unfortunately, the answer is a big no at least for the near term. Notably, Delta's president Glen Hauenstein warned that “it may be two years or more” for the revenue stream to normalize.
Even though air-travel demand showed signs of marginal recovery, particularly, on the leisure front, the spike in the coronavirus cases all across Europe (resulting in renewed lockdowns in many countries) and the same in some parts of the United States induce fears that the surge in cases might offset the improvement in travel frequency. Notably, European carrier Ryanair Holdings forecasts losses to worsen in the second half of fiscal 2021 (ending Mar 31, 2021) from the first.
Additionally, the expiry of the CARES Act on Sep 30 forced carriers like American Airlines and United Airlines to shrink their respective workforces in the face of dwindling air-travel demand. Despite some positive developments, a second round of financial aid from the government has not materialized yet, thereby making the job cuts necessary.
However, on a brighter note we expect focus to shift to a second round of federal stimulus once Biden is officially declared as the next US president. The positive vibes on the package, which came from various quarters prior to the elections, might see a further impetus leading to the much-anticipated sop eventually seeing the light of the day.
In the event of a further federal stimulus, the bruised and the battered U.S. airline stocks would surely get some relief as the pandemic grant will protect jobs in the near term and keep hopes afloat amid the existing unprecedented crisis.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
The Zacks Analyst Blog Highlights: Delta Air Lines, United Airlines, American Airlines, Southwest Airlines and Ryanair Holdings
For Immediate Release
Chicago, IL – November 10, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Delta Air Lines, Inc. (DAL - Free Report) , United Airlines Holdings, Inc. (UAL - Free Report) , American Airlines Group Inc. (AAL - Free Report) , Southwest Airlines Co. (LUV - Free Report) and Ryanair Holdings plc (RYAAY - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Coronavirus Ruins Airlines' Q3 Earnings, As Well
Airline stocks have been in the pink of health over the past few years, mainly on the back of solid passenger revenues owing to robust air-travel demand. However, with the advent of coronavirus in the first quarter of 2020, things deteriorated for the entire aviation space as travel demand plummeted with people being confined to their homes in the fear of the contagion.
What is worse is that the health peril is still very much around even though more than seven months have elapsed since the disease was declared a pandemic by the World Health Organization. Consequently, airlines continue to bear the brunt of this global adversity. As an evidence, airlines fared dismally for the third successive quarter this year with losses mounting due to crippled passenger revenues.
Against this bleak backdrop, let’s recapitulate the results of a few key airline stocks for the September quarter.
Delta Air Lines kicked off the third-quarter 2020 earnings season for the aviation industry on Oct 13. This Atlanta-GA based company incurred a loss (excluding $5.17 from non-recurring items) of $3.30 per share in the September quarter, wider than the Zacks Consensus Estimate of a loss of $3.14. Also, passenger revenues plunged 83% year over year in the September quarter. In fact, due to low demand, this key metric declined 68% in the first nine months of 2020.
Akin to Delta, Chicago-based United Airlines suffered a loss in the third successive quarter of 2020. The carrier reported a loss (excluding $1.83 from non-recurring items) of $8.16 per share in the September quarter, comparing unfavorably with the Zacks Consensus Estimate of a loss of $7.63. Passenger revenues plunged 84.3% and 68.4% in the third quarter and during the first nine months of 2020, respectively.
American Airlines posted a loss (excluding 83 cents from non-recurring items) of $5.54 per share for third-quarter 2020, narrower than the Zacks Consensus Estimate of a loss of $5.62. Passenger revenues plunged 76.9% and 64.2% in the third quarter and during the first nine months of 2020, respectively.
Dallas-based low-cost carrier Southwest Airlines fared no better and announced a loss for the third consecutive quarter like its fellow airline players mentioned above. The carrier, carrying a Zacks Rank #3 (Hold) currently, incurred a loss of $1.99 per share (excluding 3 cents from non-recurring items) in the reported quarter, narrower than the Zacks Consensus Estimate of a loss of $2.44. Moreover, passenger revenues plunged 71.2% and 61.2% in the third quarter and during the first nine months of 2020, respectively.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Any Respite Ahead?
With airlines having performed disappointingly in the third quarter, echoing the first two quarters’ trend, the million-dollar question is whether things will look up for the stocks from hereon. Unfortunately, the answer is a big no at least for the near term. Notably, Delta's president Glen Hauenstein warned that “it may be two years or more” for the revenue stream to normalize.
Even though air-travel demand showed signs of marginal recovery, particularly, on the leisure front, the spike in the coronavirus cases all across Europe (resulting in renewed lockdowns in many countries) and the same in some parts of the United States induce fears that the surge in cases might offset the improvement in travel frequency. Notably, European carrier Ryanair Holdings forecasts losses to worsen in the second half of fiscal 2021 (ending Mar 31, 2021) from the first.
Additionally, the expiry of the CARES Act on Sep 30 forced carriers like American Airlines and United Airlines to shrink their respective workforces in the face of dwindling air-travel demand. Despite some positive developments, a second round of financial aid from the government has not materialized yet, thereby making the job cuts necessary.
However, on a brighter note we expect focus to shift to a second round of federal stimulus once Biden is officially declared as the next US president. The positive vibes on the package, which came from various quarters prior to the elections, might see a further impetus leading to the much-anticipated sop eventually seeing the light of the day.
In the event of a further federal stimulus, the bruised and the battered U.S. airline stocks would surely get some relief as the pandemic grant will protect jobs in the near term and keep hopes afloat amid the existing unprecedented crisis.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.